TransCode Therapeutics Stock (RNAZ)
Track TransCode Therapeutics stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, Action Alerts PLUS portfolio activity, contributor watchlist signals, and Pro price levels.
RNAZ
TransCode Therapeutics
healthcare
$5.50
▼ -1.78 (-25.91%) past year
Market Cap
$5.12M
P/E Ratio
—
1Y Return
-25.91%
EPS (TTM)
-$48.65
Read the latest TheStreet Pro articles mentioning TransCode Therapeutics, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
0 articlesNo articles mentioning RNAZ yet.
Daily Diary Mentions
0 mentionsNo diary mentions for RNAZ yet.